MADISON, N.J., April 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that its first-quarter results will
be made public on Tuesday, April 21, before the market opens. It will hold
its quarterly conference call with investors to discuss the results beginning
at 8:30 a.m. Eastern Time on that day.
The public may access the conference call through a live audio webcast
available on Quest Diagnostics' Investor Relations Internet site at
www.QuestDiagnostics.com/investor.
The conference call can also be accessed by dialing 415-228-4961, passcode
3214469. The company suggests participants dial in approximately 10 minutes
before the call. Please note that this feature will be in listen-only mode.
A replay of the call may be accessed through the Internet at
www.QuestDiagnostics.com/investor or by dialing 866-395-9177, or 203-369-0501
for international callers. No access code will be required. Telephone replays
will be available from 10:30 a.m. Eastern Time on April 21 until midnight
Eastern Time on May 19, 2009.
Anyone listening to the Quest Diagnostics call is encouraged to read Quest
Diagnostics' periodic reports, on file with the Securities and Exchange
Commission, including the discussion of risk factors and historical results of
operations and financial condition in those reports.
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: www.QuestDiagnostics.com.
SOURCE Quest Diagnostics Incorporated
CONTACT: Laure Park (Investors): +1-973-520-2900;
or Wendy Bost (Media):
+1-973-520-2800
Web Site: http://www.questdiagnostics.com
(DGX)